Technology Review - Published By MIT
Advertisement

March/April 2010

Briefing: Personalized Medicine

Research to Watch

By TR Editors

smaller text tool iconmedium text tool iconlarger text tool icon

Project: Applied Statistical Genetics Group
Wellcome Trust Sanger Institute
www.sanger.ac.uk/research/projects/appliedstatisticalgenetics

Finding ways to analyze large amounts of genetic data and extract information related to diseases that involve multiple genes.


Project: Cancer Biology and Genetics Program
Sloan-Kettering Institute
www.mskcc.org

Testing a microfluidic chip that will measure differences in how genes are expressed in tumors.


Project: Coriell Personalized Medicine Collaborative
Coriell Institute for Medical Research
cpmc.coriell.org

Enrolling 100,000 participants in a research study to measure how genetic information can improve health.


Project: Diagnostic Investigation of Sudden Cardiac Event Risk
CardioDX
www.cardiodx.com/clinical-studies/cardiac-arrhythmia

Developing a genetic test that will identify patients at risk of sudden cardiac death who should receive an implantable defibrillator.


Project: EuroGenTest
Catholic University of Leuven and others
www.eurogentest.org

An EU-funded consortium seeking to standardize genetic testing and establish guidelines for doctors and patients.


Project: Global Alliance for Pharmacogenomics
National Institutes of Health, RIKEN Yokohama Institute
www.nigms.nih.gov/Initiatives/PGRN/GAP

An American-Japanese scientific alliance studying pharmacogenomics across a broad array of medical conditions, including depression, AIDS, and asthma.


Project: Pharmacogenomics Knowledge Base
Stanford University Medical Center and others
www.pharmgkb.org

An international consortium building a database detailing the influence of genetic variations on drug reactions.


Project: Plavix, Effient Comparative Effectiveness Study
Medco
www.medcoresearch.com/community/pharmacogenomics

Investigating whether using genetic tests to determine a patient's sensitivity to certain drugs is more cost-effective than choosing drugs that are less affected by genetic variations.


Project: The 1000 Genomes Project
Wellcome Trust Sanger Institute, Beijing Genomics Institute Shenzen, National Human Genome Research Institute
www.1000genomes.org

Sequencing the genomes of about 1,200 people around the world to create a database of biomedically relevant genetic variation.


Project: The Cancer Genome Atlas
National Cancer Institute, National Human Genome Research Institute
cancergenome.nih.gov

Sequencing thousands of samples from over 20 types of tumors to understand the genetic changes that underlie these cancers.

Comments

Technology Review Magazine

TR50
TR presents the 50 most innovative public and private companies of the year.
By TR Editors

FEATURES

Searching for Biofuels' Sweet Spot
California-based Amyris has used breakthroughs in synthetic biology to reinvent biofuels.
By Antonio Regalado
Can Twitter Make Money?
Twitter plans to become the leader in instant news--and make itself into a sustainable business in the process.
By David Talbot

Read more articles from this Issue

NOTEBOOKS TO MARKET Q&A PHOTO ESSAY REVIEWS HACK DEMO
Archives MIT News Subscribe Contact

Log In

Forgot your password?     Register »
Advertisement
Technology Review July/August 2010

Current Issue

Can AIDS Be Cured?
Researchers are pursuing radical new strategies to eliminate HIV from the body.
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES
Advertisement
MIT Massachusetts Institute of Technology © 2010 Technology Review. All Rights Reserved.